This column discusses how new and increasingly expensive therapies in the health care industry marketplace continues to cause providers, patients, and payers financial burden and how new strategies are needed to effectively manage them.
This column discusses how new and increasingly expensive therapies in the health care industry marketplace continues to cause providers, patients, and payers financial burden and how new strategies are needed to effectively manage them.
This column discusses how new...